Digestive Profiles of Human Milk, Recombinant Human and Bovine Lactoferrin: Comparing the Retained Intact Protein and Peptide Release

Abstract

Lactoferrin (LF) is a major component of human milk, and LF supplementation supports the immune system and helps maintain iron homeostasis in adults. To determine the extent to which recombinant human lactoferrin (rhLF, Effera™) produced by Komagataella phaffii digests similarly to human milk lactoferrin (hmLF), a validated in vitro digestion protocol was carried out, with bovine LF (bLF) as an additional control. The study compared intact protein retention and peptide release profiles across simulated adult gastric and intestinal digestion using gel electrophoresis, ELISA, and LC-MS. Intact LF retention across digestion was similar across LF types, though the highest iron-saturated hmLF had greater retention in simulated gastric fluid. Peptides identified in digested hmLF strongly correlated with digested rhLF (0.86-0.92 in the gastric phase, 0.63-0.70 in the intestinal phase), whereas digested bLF was significantly different. These findings support the potential for rhLF as a food ingredient for human consumption.

Full Paper

Category
Published Papers
Journal
Nutrients
Publication date
July 20, 2024
Authors
BK
Bum Jin Kim
Bum Jin Kim
PhD researcher in the Dallas Lab at Oregon State University, specializing in mass spectrometry characterization of milk proteins, peptides, and glycopeptides.
RK
Russell F. Kuhfeld
Russell F. Kuhfeld
MS researcher in the Dallas Lab at Oregon State University, studying peptide release in milk and cheese digestion.
JH
Joanna L. Haas
Joanna L. Haas
MS student and later Faculty Research Assistant (2022-2024) in the Dallas Lab at Oregon State University, studying whey protein's effects on immune function in older adults.
YA
Yanisa Anaya
Yanisa Anaya
Biomedical engineer; Associate/Entry-level Scientist at Helaina, contributing to allergenicity risk assessment of recombinant human lactoferrin.
RM
Raysa Rosario Martinez
Raysa Rosario Martinez
Associate Scientist in Nutritional Biology & Safety at Helaina, Inc., co-author on human lactoferrin food-allergy risk research.
BS
Baidya Nath P. Sah
Baidya Nath P. Sah
Former postdoctoral scholar (2018-2020) in the Dallas Lab at Oregon State University, researching survival of antibodies during infant digestion.
BB
Bella Breen
Bella Breen
Associate Scientist in Late Stage R&D at Helaina, Inc., co-author of the Helaina food-allergy-risk evaluation of recombinant human lactoferrin.
KN
Kahler Newsham
Kahler Newsham
Lead downstream/bioprocess engineer at Helaina (chemical engineering, Tufts University), works on purifying fermentation output into effera lactoferrin powder.
CM
Carrie-Anne Malinczak
Carrie-Anne Malinczak
PhD immunologist; Director/Head of Immunology at Helaina, Inc., co-author on Helaina recombinant human lactoferrin safety studies.
DD
David C. Dallas
David C. Dallas
Associate Professor of Nutrition at Oregon State University, studying digestion of human and dairy milk proteins and release of bioactive peptides.

Ready to build the future?

effera® is more than an ingredient; it's a platform for innovation.
If you're ready to move beyond legacy ingredients and create a product that's truly aligned with human biology, we're ready to talk.